4538
K. Kobayashi et al. / Tetrahedron 67 (2011) 4535e4538
added AcNMe2 (0.11 g, 1.2 mmol). After 15 min a solution of 1a
(0.25 g, 1.2 mmol) in THF (2 mL) was added and the stirring was
continued for 30 min before saturated aqueous NH4Cl (15 mL) was
added. The mixture was extracted with AcOEt three times (10 mL
each), and the combined extracts were washed with brine (10 mL)
and dried over anhydrous Na2SO4. After evaporation of the solvent
the residual solid was purified by recrystallization from hex-
aneeCHCl3 to give 4a (0.22 g, 63%); a pale-yellow solid; mp
179e180 ꢁC; IR (KBr) 3167,1618,1602,1169 cmꢀ1; 1H NMR(500 MHz)
(KBr) 3198, 1740, 1631, 1609, 1163 cmꢀ1; 1H NMR (600 MHz)
d 3.18 (d,
J¼16.0 Hz,1H), 3.25 (s, 3H), 3.30 (d, J¼16.0 Hz,1H), 3.59 (s, 3H), 3.81 (s,
3H), 6.77 (d, J¼2.9 Hz,1H), 6.87 (d, J¼8.6 Hz,1H), 6.92 (dd, J¼8.6, 2.9 Hz,
1H), 9.79 (br s, 1H); 13C NMR (125 MHz, CDCl3)
d 45.75, 51.35, 51.96,
55.70,106.23,110.11,115.47,116.69,118.98,127.31,157.26,167.99,181.45;
MS m/z 297 (Mþ, 5.8), 266 (100). Anal. Calcd for C13H15NO5S: C, 52.51;
H, 5.09; N, 4.71. Found: C, 52.33; H, 5.19; N, 4.49.
3.4.7. 1,1-Dimethylethyl 2-(6-chloro-4-ethoxy-2-thioxo-1,4-dihydro-
d
1.18 (t, J¼7.4 Hz, 3H), 2.84 (s, 3H), 3.05 (s, 3H), 3.20 (d, J¼15.5 Hz,
3,1-benzoxazin-4-yl)acetate (4g). A white solid; mp 158e159 ꢁC
1H), 3.24e3.29 (m, 1H), 3.38 (d, J¼15.5 Hz, 1H), 3.54e3.59 (m, 1H),
6.81 (d, J¼8.0 Hz,1H), 7.15 (td, J¼7.4,1.1 Hz,1H), 7.23 (dd, J¼7.4,1.1 Hz,
1H), 7.29 (ddd, J¼8.0, 7.4, 1.1 Hz, 1H), 9.56 (br s, 1H); 13C NMR
(hexaneeCH2Cl2); IR (KBr) 3185, 1724, 1619, 1170 cmꢀ1 1H NMR
;
(500 MHz)
d
1.19 (t, J¼6.9 Hz, 3H), 1.29 (s, 9H), 3.09 (d, J¼15.5 Hz, 1H),
3.26 (d, J¼15.5 Hz, 1H), 3.33e3.39 (m,1H), 3.55e3.61 (m,1H), 6.87 (d,
J¼8.6Hz,1H), 7.27(d,J¼2.3Hz,1H),7.33(dd,J¼8.6,2.3Hz,1H),9.99(br
(150 MHz, DMSO-d6)
d 14.73, 34.49, 36.65, 43.43, 58.00, 105.62,
113.71, 119.42, 124.20, 125.02, 129.67, 133.88, 166.64, 181.28; MS m/z
(%) 294 (Mþ, 6.0), 249 (100). Anal. Calcd for C14H18N2O3S: C, 57.12; H,
6.16; N, 9.52. Found: C, 56.95; H, 6.21; N, 9.48.
s, 1H); 13C NMR (125 MHz, CDCl3)
d 14.79, 27.75, 47.50, 59.94, 82.01,
105.82,115.25,120.54,125.50,130.37,130.76,131.86,166.41,182.14;MS
m/z 357 (Mþ, 7.0), 312 (24), 301 (100). Anal. Calcd for C16H20ClNO4S: C,
53.70; H, 5.63; N, 3.91. Found: C, 53.68; H, 5.69; N, 3.87.
3.4.2. 2-(4-Ethoxy-2-thioxo-1,4-dihydro-3,1-benzoxazin-4-yl)-N,
N-diethylacetamide (4b). A white solid; mp 151e152 ꢁC (hex-
3.5. Ethyl 2-(thiopropanoylamino)benzoate (5)9
aneeCH2Cl2); IR (KBr) 3196, 1624, 1604, 1172 cmꢀ1 1H NMR (500
;
MHz3)
d
1.01 (t, J¼7.4 Hz, 3H), 1.18 (t, J¼6.9 Hz, 6H), 3.18 (d, J¼15.5 Hz,
To a stirred solution of 1a (0.21 g, 1.0 mmol) in THF (4 mL) at
ꢀ78 ꢁC was added EtMgBr (3 M in Et2O; 1.0 mmol) dropwise. After
20 min saturated aqueous NH4Cl (10 mL) was added and the
mixture was extracted with AcOEt three times (10 mL each). The
combined extracts were washed with brine (10 mL), dried over
anhydrous Na2SO4, and concentrated by evaporation. The residue
was purified by preparative TLC on silica gel to give 5 (86 mg,
36%); a yellow oil; Rf 0.16 (hexane); IR (neat) 3250, 1694, 1609,
1H), 3.18e3.35 (m, 4H), 3.35 (d, J¼15.5 Hz, 1H), 3.39e3.46 (m, 1H),
3.54e3.60 (m, 1H), 6.79 (d, J¼8.0 Hz, 1H), 7.16 (ddd, J¼8.0, 7.4, 1.1 Hz,
1H), 7.24 (d, J¼8.0 Hz, 1H), 7.30 (ddd, J¼8.0, 7.4, 1.1 Hz, 1H), 9.41 (br s,
1H); 13C NMR (150 MHz, CDCl3)
d 12.83, 14.24, 14.79, 40.23, 42.36,
45.19, 59.64,107.49,114.11,119.16,124.77,125.23,130.20,133.63,165.97,
182.38; MS m/z 322 (Mþ, 8.2), 277 (100). Anal. Calcd for C16H22N2O3S:
C, 59.60; H, 6.88; N, 8.69. Found: C, 59.54; H, 6.95; N, 8.59.
1263 cmꢀ1
;
1H NMR (500 MHz)
d
1.428 and 1.433 (2t, J¼7.8 and
3.4.3. 2-(4-Ethoxy-2-thioxo-1,4-dihydro-3,1-benzoxazin-4-yl)-1-
(pyrrolidin-1-yl)ethanone (4c). A white solid; mp 158e161 ꢁC (hex-
aneeCH2Cl2); IR (KBr) 3171, 1614, 1601, 1165 cmꢀ1; 1H NMR (500 MHz,
6.8, respectively, combined 6H), 2.92 (q, J¼7.8 Hz, 2H), 4.41 (q,
J¼6.8 Hz, 2H), 7.23 (dd, J¼8.8, 7.8 Hz, 1H), 7.60 (ddd, J¼8.8, 7.8,
2.0 Hz, 1H), 8.10 (d, J¼7.8 Hz, 1H), 9.54 (d, J¼8.8 Hz, 1H), 12.39 (br s,
CDCl3)
d
1.18 (t, J¼6.9 Hz, 3H),1.74e2.02 (m, 4H), 3.11 (d, J¼15.5 Hz, 1H),
1H); 13C NMR (150 MHz, CDCl3)
d 13.77, 14.14, 43.79, 61.74, 117.64,
3.27e3.44 (m, 5H), 3.55e3.61 (m, 2H), 6.78 (d, J¼8.0 Hz, 1H), 7.16 (td,
121.54, 124.63, 130.91, 133.72, 141.59, 168.08, 206.34; MS m/z 237
J¼7.4,1.1 Hz,1H), 7.26 (d, J¼7.4 Hz,1H), 7.30 (ddd, J¼8.0, 7.4,1.1 Hz,1H),
(Mþ, 100).
9.29 (br s, 1H); 13C NMR (125 MHz, CDCl3)
d 14.81, 24.28, 26.07, 45.83,
46.91, 47.16, 59.62,107.37,114.29,119.04,124.77,125.23,130.24,133.72,
165.36, 182.31; MS m/z 320 (Mþ, 6.5), 275 (100). Anal. Calcd for
C16H20N2O3S: C, 59.98; H, 6.29; N, 8.74. Found: C, 59.90; H, 6.40; N, 8.52.
Acknowledgements
This work was partially supported by a Grant-in-Aid for Scien-
tific Research (C) 22550035 from Japan Society Fro the Promotion of
Science. We thank Mrs. Miyuki Tanmatsu of this university for as-
sistance in recording mass spectra and performing combustion
analyses.
3.4.4. Ethyl 2-(4-ethoxy-2-thioxo-1,4-dihydro-3,1-benzoxazin-4-yl)
acetate (4d). A white solid; mp 84e87 ꢁC (hexaneeCH2Cl2); IR (KBr)
3194, 1738, 1622, 1605, 1161 cmꢀ1 1H NMR (500 MHz)
; d 1.11 (t,
J¼7.4 Hz, 3H), 1.18 (t, J¼7.4 Hz, 3H), 3.19 (d, J¼16.6 Hz, 1H), 3.28e3.34
(m, 2H), 3.55e3.61 (m, 1H), 3.97e4.03 (m, 2H), 6.91 (d, J¼7.4 Hz, 1H),
7.19 (td, J¼7.4,1.1 Hz,1H), 7.27 (dd, J¼8.0,1.1 Hz,1H), 7.36 (ddd, J¼8.0,
References and notes
7.4,1.1Hz,1H), 9.95(brs,1H); 13CNMR (150MHz,CDCl3)
d13.87, 14.78,
46.50, 59.83, 60.91, 106.22, 113.88, 118.59, 125.26, 125.40, 130.68,
133.37,167.57,182.53; MS m/z 295 (Mþ, 5.4), 250 (100). Anal. Calcd for
C14H17NO4S:C,56.93;H, 5.80;N,4.74.Found:C,56.82;H, 5.94;N,4.52.
1. (a) Fensome, A.; Bender, R.; Chopra, R.; Cohen, J.; Collins, M. A.; Hudak, V.;
Malakian, K.; Lockhead, S.; Olland, A.; Svenson, K.; Terefenko, E. A.; Unwalla, R. J.;
Wilhelm, J. M.; Wolform, S.; Zhu, Y.; Zhang, Z.; Zhang, P.; Winneker, R. C.;
Wrobel, J. J. Med. Chem. 2005, 48, 5092e5095; (b) Kern, J. C.; Terefenko, E. A.;
Fensome, A.; Unwallla, R.; Wrobel, J.; Zhu, Y.; Cohen, J.; Winneker, R.; Zhang, Z.;
Zhang, P. Bioorg. Med. Chem. Lett. 2007, 17, 189e192; (c) Nakagawa, A.; Uno, S.;
Makishima, M.; Miyachi, H.; Hashimoto, Y. Bioorg. Med. Chem. 2008, 16,
7046e7054; (d) Zhou, H.-B.; Lee, J. H.; Mayne, C. G.; Carson, K. E.; Katze-
nellenbogen, J. A. J. Med. Chem. 2010, 53, 3349e3360.
2. Kobayashi, K.; Yokoi, Y.; Komatsu, T.; Konishi, H. Tetrahedron 2010, 66,
9336e9339.
3. Theeraladanon, C.; Arisawa, M.; Nishida, A.; Nakagawa, M. Tetrahedron 2004, 60,
3017e3035.
3.4.5. 2-(4-Methoxy-2-thioxo-1,4-dihydro-3,1-benzoxazin-4-yl)-1-
(piperidin-1-yl)ethanone (4e). A pale-yellow solid; mp 154e156 ꢁC
(hexaneeCH2Cl2); IR (KBr) 3198, 1647, 1624, 1601, 1171 cmꢀ1 1H
;
NMR (600 MHz)
d
1.45e1.61 (m, 6H), 3.20 (s, 3H), 3.26 (d, J¼15.4 Hz,
1H), 3.38 (d, J¼15.4 Hz, 1H), 3.40e3.51 (m, 4H), 6.86 (d, J¼7.9 Hz,
1H), 7.15 (td, J¼7.5, 1.0 Hz, 1H), 7.25 (d, J¼7.5 Hz, 1H), 7.27 (ddd,
J¼7.9, 7.5, 1.0 Hz, 1H), 10.33 (br s, 1H); 13C NMR (125 MHz, CDCl3)
4. Kobayashi, K.; Takanohashi, A.; Hashimoto, K.; Morikawa, O.; Konishi, H. Tetra-
hedron 2006, 62, 3158e3161.
5. Kobayashi, K.; Yoneda, K.; Miyamoto, K.; Morikawa, O.; Konishi, H. Tetrahedron
d
24.36, 25.42, 26.31, 42.76, 44.66, 47.27, 51.22, 107.58, 114.27,
118.45, 124.84, 125.36, 130.37, 133.80, 165.11, 182.36; MS m/z 320
(Mþ, 5.8), 289 (100). Anal. Calcd for C16H20N2O3S: C, 59.98; H, 6.29;
N, 8.74. Found: C, 59.82; H, 6.40; N, 8.51.
2004, 60, 11639e11645.
6. Ito, Y.; Kobayashi, K.; Seko, N.; Saegusa, T. Bull. Chem. Soc. Jpn. 1984, 57, 73e84.
7. Fujiwara, S.; Shin-Ike, T.; Sonoda, N.; Aoki, M.; Okada, K.; Miyoshi, N.; Kambe, N.
Tetrahedron Lett. 1991, 32, 3503e3506.
8. Venugopalan, B.; Bapat, C. P.; Kaenik, P. J.; Chatterjee, D. K.; Iyer, N.; Lepcha, D.
J. Med. Chem. 1995, 38, 1922e1927.
9. Clausen, K.; Lawesson, S. O. Bull. Soc. Chim. Belg. 1979, 88, 305e311.
3.4.6. Methyl 2-(4,6-dimethoxy-2-thioxo-1,4-dihydro-3,1-benzoxazin-
4-yl)acetate (4f). A white solid; mp 171e173 ꢁC (hexaneeCH2Cl2); IR